A recent report has evaluated the protective effect of pinocembrin on colitis, whereby it suppresses gut microbiota and toll like receptor 4/myeloid differentiation factor 2/NF-κB pathway but enhances the intestinal barrier by upregulating the expression of tight junction proteins [21]. This evidence concerns the gene NFKB1 and colitis.